Myriad Genetics Third Quarter 2023 Financial Earnings

Watch the videoDownload presentation

Events & Presentations

View all events

Financial Reports and Filings

Date Filing Title Downloads
12/05/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/13/2023 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
11/13/2023 424B5 Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 RTF XLS PDF HTML XBRL
11/09/2023 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
11/08/2023 424B5 Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 RTF XLS PDF HTML XBRL
11/08/2023 S-3ASR S-3ASR RTF XLS PDF HTML XBRL
11/07/2023 10-Q Quarterly report which provides a continuing view of a company's financial position RTF XLS PDF HTML XBRL
11/06/2023 8-K Report of unscheduled material events or corporate event RTF XLS PDF HTML XBRL
11/03/2023 4 Statement of changes in beneficial ownership of securities RTF XLS PDF HTML XBRL
11/01/2023 144 Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing RTF XLS PDF HTML XBRL
View all filings

Latest News

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents Thumbnail

Myriad Genetics Celebrates One Million SneakPeek® Results Shared with Expectant Parents

Nov 20, 2023 | Products

Read more
Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers Thumbnail

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Nov 16, 2023 | Corporate | Products

Read more
Myriad Genetics to Participate in Stephens Annual Investment Conference Thumbnail

Myriad Genetics to Participate in Stephens Annual Investment Conference

Nov 09, 2023 | Corporate

Read more
View all news releases

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics

Our commitment to social responsibility

At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.

Learn more about the actions we’re taking in ESG

Read our ESG report
“As a leader in genetic testing and precision medicine, we understand the important role we play in advancing health equity and social justice. We also recognize our responsibility to operate in harmony with the environment which includes efforts to minimize our impact on the climate. These topics are directly linked with our purpose and values. We are proud to release our second annual environmental, social, and governance (ESG) report."

— Paul Diaz
President and CEO of Myriad Genetics